Curve Dental vs Labcorp
Side-by-side comparison of AI visibility scores, market position, and capabilities
Cloud dental practice management software offering an all-in-one platform for single offices and growing dental groups. Layton UT; founded 2004; one of the earliest true cloud dental PMS alternatives to legacy Dentrix and Eaglesoft;
About
Curve Dental is a Layton, Utah-based cloud-based dental practice management software company that offers an all-in-one platform combining scheduling, clinical charting, digital imaging, billing, and patient communication in a single browser-based application. Founded in 2004, Curve was among the early movers in cloud dental practice management and has built a platform specifically for independent dental practices and small group practices that want a modern, easy-to-use alternative to legacy on-premise systems like Dentrix and Eaglesoft. Curve's cloud architecture means there is no local server to maintain, no software to install or update, and no data backup to manage—the entire system is accessed through a web browser from any device with an internet connection.\n\nCurve's integrated imaging capability—including digital X-ray sensor compatibility, intraoral camera support, and panoramic image management—is a key differentiator in the cloud practice management market, where many competitors require a separate imaging software. By managing clinical imaging and scheduling in the same platform, Curve eliminates the need to switch between systems during patient appointments and ensures that radiographs are automatically associated with the correct patient chart and treatment records. The platform's clinical charting module supports periodontal charting, treatment planning, electronic prescriptions, and clinical notes in a unified workflow designed for the pace of a busy dental office.\n\nCurve Dental competes with Dentrix Ascend (Henry Schein's cloud offering), Eaglesoft Cloud, Carestream, and Planet DDS's Denticon in the dental practice management market. The company targets single-office practices and small groups of up to 10 locations that want cloud convenience without the enterprise complexity of DSO-focused platforms. Curve differentiates on the all-in-one nature of its platform—imaging included at no additional cost—and the simplicity of its pricing and onboarding experience for practices transitioning from legacy systems.
Burlington NC clinical laboratory services (NYSE: LH) ~$13.1B FY2024 revenue; Fortrea CRO spun off 2023, 2000+ PSC network, specialty oncology molecular testing competing with Quest Diagnostics.
About
Laboratory Corporation of America Holdings (Labcorp) is a Burlington, North Carolina-based clinical laboratory and life sciences company — publicly traded on the New York Stock Exchange (NYSE: LH) as an S&P 500 Health Care component — providing diagnostic laboratory testing services for physicians, hospitals, health systems, and patients across the United States and internationally, and providing drug development laboratory services (biopharmaceutical clinical trial laboratory support) through approximately 60,000 employees. In fiscal year 2024, Labcorp reported revenues of approximately $13.1 billion from the Diagnostics segment — following the June 2023 separation of its Drug Development segment as Fortrea Holdings (NASDAQ: FTRE), an independent public company providing CRO (contract research organization) services to pharmaceutical and biotech clients. CEO Adam Schechter has focused the post-Fortrea Labcorp on the pure-play diagnostics business: clinical testing across 6,000+ test menu items (routine blood work, specialty genetic testing, toxicology, and anatomic pathology) processed at Labcorp's 2,000+ patient service centers and sent to regional and specialty reference laboratories for results reporting to ordering physicians. The Labcorp consumer-direct testing initiative (at-home specimen collection kits for STI testing, COVID testing, and other direct-to-consumer tests ordered at labcorp.com without physician referral) expands beyond the traditional physician-ordered testing model to capture the growing consumer health testing market. Labcorp's specialty testing portfolio (oncology genomic profiling, rare disease genetic panels, prenatal cell-free DNA testing, advanced cardiac biomarker panels) generates higher revenue per requisition than routine chemistry and hematology panels — driving mix shift toward specialty and molecular testing revenue.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.